FDA Makes It Formal, Rescinds SPA For Amarin’s ANCHOR Study
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency makes clear that triglyceride levels are no longer an acceptable surrogate for reducing cardiovascular risk.